Herb Profile
Turmeric Curcuma Longa
Curcuma longa
Turmeric (Curcuma longa) is a culinary rhizome whose curcuminoids, including curcumin and demethoxycurcumin, are studied in concentrated extracts.
Last reviewed: •4 sources citedReport a correctionProfile-wide ·B Moderate
Use extra caution — Safety evidence: short term human trials provide limited, preparation specific safety data. Details
- Evidence
- Moderate Evidence
- Typical onset
- Varies by prep
- Safety rating
- High caution
- Best for
- Anti Inflammatory, Antioxidant, Joint Support, Inflammation
- Avoid / review if
- Use Caution With Anticoagulant Or Antiplatelet Therapy, Before Surgery, And With Gallbladder Or Bile Duct Disease
Verdict: Turmeric Curcuma LongaSituation-dependent
Bottom line
Turmeric root is roughly 2–5% curcuminoids and poorly absorbed, so a teaspoon in food is nowhere near what the clinical trials used. If you want the studied effect, the decision is really about curcumin extract — turmeric is the spice, not the intervention.
- Evidence confidence
- The spice and the studied extract are not interchangeable
- Expected onset
- Not meaningfully measurable at culinary intakes
- Give it
- n/a for culinary use; 8–12 weeks if using a standardized extract
Safety: Culinary amounts are well tolerated. Concentrated supplements carry the same cautions as curcumin: anticoagulant interaction, gallstones, and rare liver-injury reports.
On the evidence: Nearly all positive human evidence comes from standardized curcuminoid extracts, not whole turmeric at dietary intakes.
Best for
- Culinary use and general dietary variety
- People who prefer whole-root preparations and accept a smaller effect
Not ideal for
- Reproducing the joint-pain results from curcumin extract trials
- Anyone expecting a therapeutic dose from cooking
Consider instead: Curcumin — this is the form the clinical trials actually tested
Expanded editorial review
What this profile is built to answer
Informational to commercial: understand turmeric versus curcumin, bioavailability forms, joint/inflammation evidence, and safety cautions before buying.
- Separate culinary turmeric from concentrated curcumin extracts.
- Rank forms by human evidence, bioavailability strategy, and safety tradeoffs.
- Make anticoagulant, gallbladder, surgery, pregnancy, and GI cautions visible before product guidance.
| Use case | Evidence | Best fit | Typical range | Safety context |
|---|---|---|---|---|
| Joint comfort / osteoarthritis | Moderate | Adults comparing non-NSAID joint-support options | Often 500-1,000 mg/day curcuminoids or formulated equivalent | Medication and gallbladder context matter. |
| Inflammatory signaling | Mechanistic to moderate | NF-kB/Nrf2 pathway context | Form-dependent; do not infer from spice dose | Do not treat inflammatory disease without care. |
| Gut and metabolic context | Preliminary | Curcumin-focused experiments | Trial-dependent extracts | Can aggravate reflux or GI upset. |
| Plain turmeric powder | Low for targeted effects | Food use, not high-potency supplementation | Culinary amounts vary | Low dose but lower bioavailability. |
Product and form choices
- Curcumin phytosome
- Best premium defaultImproves absorption without relying on piperine interaction risk.
- Curcumin + piperine
- Potent but interaction-awarePiperine can affect drug metabolism and tolerability.
- Liposomal/nano forms
- Consider if testedBioavailability claims need brand-specific evidence.
- Turmeric powder
- Food-firstUseful culinary ingredient, but not equivalent to studied extracts.
Safety checks
- Use clinician guidance with anticoagulants, antiplatelets, bleeding disorders, or upcoming surgery.
- Avoid self-directed high-dose curcumin with gallstones, bile-duct obstruction, or severe reflux unless a clinician clears it.
- Piperine-containing products may change medication exposure; choose non-piperine forms when interaction risk is a concern.
How to choose a product
- Choose curcuminoid amount and form, not just total turmeric weight.
- Decide whether piperine is appropriate for your medication context.
- Prefer third-party tested products for heavy metals and adulterants.
- Expect gradual joint-support trials over weeks, not same-day pain relief.
Safety
Safety & Cautions
Safety evidence: short term human trials provide limited, preparation specific safety data. Mild gastrointestinal effects can occur; the existing workbook cautions for bleeding risk therapy, surgery, biliary disease, pregnancy, and breastfeeding remain precautionary and require individualized review.
High caution
Caution level: High. Multiple caution categories apply, or the record uses avoid/contraindication language.
- Interaction-AwareMedication or interaction context is explicitly noted.
- Anticoagulant CautionBleeding or anticoagulant-adjacent caution language is present.
- Pregnancy/Breastfeeding CautionPregnancy or breastfeeding caution language is present.
Detailed safety fields
Pregnancy, breastfeeding, and contraindications
- Use Caution With Anticoagulant Or Antiplatelet Therapy
- Before Surgery
- And With Gallbladder Or Bile Duct Disease
Safety classifications
- Interaction-Aware: Medication or interaction context is explicitly noted.
- Anticoagulant Caution: Bleeding or anticoagulant-adjacent caution language is present.
- Pregnancy/Breastfeeding Caution: Pregnancy or breastfeeding caution language is present.
Full safety note
- Safety evidence: short term human trials provide limited, preparation specific safety data. Mild gastrointestinal effects can occur; the existing workbook cautions for bleeding risk therapy, surgery, biliary disease, pregnancy, and breastfeeding remain precautionary and require individualized review.
Safety labels
- Interaction-Aware
- Anticoagulant Caution
- Pregnancy/Breastfeeding Caution
Evidence-based safety
Caution when combined
Severity and certainty are shown separately. A high-priority caution can still be theoretical: these pairings are screened from shared contraindication mechanisms and are not automatically documented clinical interactions. Provenance identifies the source fields that produced each flag; it does not upgrade the certainty of the pairwise claim.
High-Priority Caution
147 flagged pairingsBleeding / anticoagulant risk
High-Priority Caution
147 flagged pairingsBleeding / anticoagulant risk
Representative pairings are shown below. Large mechanism groups are intentionally summarized to keep profiles focused and crawl-efficient.
Bleeding / anticoagulant riskCertainty: Theoretical
Data provenance recorded for 147 of 147 pairings in this mechanism group.
- aescin — Theoretical interaction certainty
- Aged Garlic Extract — Theoretical interaction certainty
- ajoene — Theoretical interaction certainty
- Ajwain — Theoretical interaction certainty
- Allicin — Theoretical interaction certainty
- Garlic — Theoretical interaction certainty
- American Ginseng Extract — Theoretical interaction certainty
- Andrographis — Theoretical interaction certainty
- Angelica Archangelica — Theoretical interaction certainty
- Angelica Dahurica — Theoretical interaction certainty
- Angelica Pubescens — Theoretical interaction certainty
- Angelica Root — Theoretical interaction certainty
+135 more pairings share this mechanism. Use the Safety Checker to review a specific combination.
Evidence
Evidence Summary
Evidence lens
Useful signal, but study design, dose, and population still matter.
ModerateModerate Evidence
Human clinical evidence: Present in source signals
Mechanistic / preclinical: Mechanism mapped — Inflammatory Signaling Modulation · Oxidative Stress Modulation · Metabolic Regulation
Research maturity: Established research — Long Term Human Evidence May Be Limited.
Safety boundary: Safety note available — Safety evidence: short term human trials provide limited, preparation specific safety data.
This profile cites 4 human studies.
Study design details
Evidence Grade
Grade B: Moderate Evidence
Evaluation of methodological rigor, population reach, and evidence alignment.
- Design Match
- Systematic review
- Risk of Bias
- Low
- Consistency
- Consistent
Strongest recorded design is a systematic review, drawn from 5 recorded studies, 3 in people. No disagreement is recorded across them.
How evidence grades work
Each grade reflects the strength and consistency of published human evidence — not marketing claims. Grades are based on study count, design quality, effect size, consistency, and recency.
- Strong
- Multiple RCTs, consistent direction, adequate effect size
- Moderate
- Some RCTs or consistent observational data in humans
- Preliminary / Mixed
- Animal or in-vitro only, or conflicting human data
- Traditional / Theoretical
- Traditional use only; no controlled human trials
Clinical Study Summaries (5)2 human evidence sources · 1 human trial · ~367 participants across 1 human evidence source with reported N · Consistency not yet classifiable
Filter by study class
Showing 5 of 5 studies.
What the evidence actually shows
This table contains 5 structured sources, including 2 human evidence sources; 1 is a human trial. Across 1 human evidence source with a reported sample size, the approximate participant total is 367; overlapping publications may include some of the same people.
| Study | Design | N | Dose | Duration | Population | Outcome | Result & magnitude | Source |
|---|---|---|---|---|---|---|---|---|
Effects of Turmeric (Curcuma longa) on Skin Health: A Systematic Review of the Clinical Evidence Vaughn AR et al. · Phytother Res · 2016 Background | Systematic review Uses a predefined method to find and evaluate relevant studies, but may or may not pool their results statistically. | — | — | — | — | — | — | PubMed → |
PubMed · Clin Interv Aging · 2014 Background | Randomized controlled trial Randomly assigns participants to interventions or controls, reducing many sources of bias when the trial is conducted well. | n=367 | — | — | — | — | — | PubMed → |
Curcumin, an active component of turmeric (Curcuma longa), and its effects on health Kocaadam B et al. · Crit Rev Food Sci Nutr · 2017 Background | Narrative review Summarizes selected literature without the full prespecified search and selection methods of a systematic review. | — | — | — | — | — | — | PubMed → |
Ayurvedic Herbal Medicines: A Literature Review of Their Applications in Female Reproductive Health Patibandla S et al. · Cureus · 2024 Background | Narrative review Summarizes selected literature without the full prespecified search and selection methods of a systematic review. | — | — | — | — | — | — | PubMed → |
Turmeric — LiverTox: Clinical and Research Information on Drug-Induced Liver Injury National Institute of Diabetes and Digestive and Kidney Diseases · NIH LiverTox · 2025 Background | Narrative review Summarizes selected literature without the full prespecified search and selection methods of a systematic review. | — | — | — | — | — | — | PubMed → |
Dosing & Timing
- Dose guidance
- 500 1,500 mg/day standardized curcumin extract, often split doses
How Turmeric Curcuma Longa works
Simplified mechanism pathway based on preclinical and pharmacological evidence. Does not confirm clinical efficacy.
Mechanism Pathway — How Turmeric Curcuma Longa Works
CompoundTarget / ReceptorMechanismEffect / Outcome
Mechanisms & biological pathways (preclinical)
- Inflammatory Signaling Modulation
- Oxidative Stress Modulation
- Metabolic Regulation
- Stress Response Modulation
- NF KB Modulation
- Nrf2 Activation
Active Compounds
Key constituents studied in Turmeric Curcuma Longa, with full pharmacology and safety profiles.
Compare related active botanicals
Explore botanicals with similar chemistry, effects, or safety considerations in the Botanical Activity Atlas.
Compare & Sourcing
Compare side-by-side tradeoffs or verify active marker guidelines.
Sourcing options
Turmeric / Curcumin product picks
Recommendation status
Product recommendations are not shown for this profile because the current site safety and monetization policy does not permit them.
Product form & quality guidelines
When sourcing Turmeric Curcuma Longa, verify the label for:
- Standardized extract: Confirm active content percentages on the supplement facts panel (e.g. standardized to specific marker compounds) rather than simple raw herb weights.
- Third-party testing: Look for independent purity labels (USP, NSF, ConsumerLab, or Eurofins) to ensure the product is free from heavy metals, solvents, and contaminants.
- Form bioavailability: Ensure the form matches evidence-supported configurations (e.g. standardized active extracts like bacosides, withanolides, or curcuminoids) for optimal onset and digestion tolerance.
Safety first · Harm reduction
This information is educational and not medical advice. Start low, avoid risky combinations, and consult a licensed clinician before making health decisions—especially if you use medications, have diagnosed conditions, or are pregnant/breastfeeding.
Learn how we evaluate confidence, safety, and intensity on the methodology page.
Founder & Head Researcher · Oak Ridge, TN · Last reviewed August 2026
Editorial Review
Checked against primary sources, cited evidence, and contraindication language before publication. Evidence claims, safety language, and affiliate modules are reviewed independently. Not personal medical advice.
Help improve this profile
Was this useful for your research?
These controls record only the page and the structured choice you make when analytics consent is enabled. Please don’t include personal medical information in research requests.
Was this evidence summary clear?
Did you find what you were researching?
Free safety checklist
Get the Turmeric Curcuma Longa research notes
Evidence summaries, dosing context, and safety updates for this herb — straight to your inbox.
We use your email to send the checklist and occasional evidence-first supplement updates. Unsubscribe anytime. Privacy policy.